Results 91 to 100 of about 2,244,720 (326)

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

Editorial: Transformable structures and envelopes in architecture and civil engineering

open access: yesFrontiers in Built Environment, 2023
Marios C. Phocas, Maria Matheou
doaj   +1 more source

Sketch-Based Interfaces to Support Collaborative Conceptual Design Learning [PDF]

open access: yes, 2007
In order to gain a better understanding of online collaborative conceptual design processes this paper investigates how student designers make use of Lyceum, a shared virtual synchronous environment when engaged in conceptual design. The software enables
Aczel, James   +3 more
core  

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

A conceptual design tool: Sketch and fuzzy logic based system [PDF]

open access: yes, 2001
A real time sketch and fuzzy logic based prototype system for conceptual design has been developed. This system comprises four phases. In the first one, the system accepts the input of on-line free-hand sketches, and segments them into meaningful parts ...
Jordanov, IN, Qin, SF, Wright, DK
core  

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

open access: yesMolecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié   +16 more
wiley   +1 more source

Conceptual design summary [PDF]

open access: yes, 1992
The Advanced Neutron Source (ANS) is a new basic and applied research facility based on a powerful steady-state research reactor that provides beams of neutrons for measurements and experiments in the fields of materials science and engineering, biology, chemistry, materials analysis, and nuclear science.
openaire   +4 more sources

Solar sustained plasma/absorber conceptual design [PDF]

open access: yes
A space power system concept was evaluated which uses concentrated solar energy to heat a working fluid to temperatures as high as 4000 K. The high temperature working fluid could be used for efficient electric power production in advanced thermal or ...
Kendall, J. S.   +2 more
core   +1 more source

Conceptual design of harvesting energy system for road application [PDF]

open access: yes, 2013
Energy harvesting becomes more and more important in our life. It refers to the practice of acquiring energy from the environment which would be otherwise wasted and converting it into usable electric energy.
Mihaj, Kamarul Faiz
core  

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy